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Entamoeba histolytica is a protozoan parasite that causes amoebic dysentery and liver abscess. Vesicle
trafficking events, such as phagocytosis and delivery of plasma membrane proteins, have been implicated in
pathogenicity. Rab GTPases are proteins whose primary function is to regulate vesicle trafficking; therefore,
understanding the function of Rabs in this organism may provide insight into virulence. E. histolytica possesses
a number of unique Rabs that exhibit limited homology to host Rabs. In this study we examined the function
of one such Rab, EhRabA, by characterizing a mutant overexpressing a constitutively GTP-bound version of the
protein. Overexpression of mutant EhRabA resulted in decreased adhesion to and phagocytosis of human red
blood cells and in the appearance of large tubular organelles that could be stained with endoplasmic reticulum
(ER)-specific but not Golgi complex-specific antibodies. Consistent with the adhesion defect, two subunits of
a cell surface adhesin, the galactose/N-acetylgalactosamine lectin, were mislocalized to the novel organelle. A
cysteine protease, EhCP2, was also localized to the ER-like compartment in the mutant; however, the localization of two additional cell surface proteins, Igl and SREHP, remained unchanged in the mutant. The
phenotype of the mutant could be recapitulated by treatment with brefeldin A, a cellular toxin that disrupts
ER-to-Golgi apparatus vesicle traffic. This suggests that EhRabA influences vesicle trafficking pathways that
are also sensitive to brefeldin A. Together, the data indicate that EhRabA directly or indirectly influences the
morphology of secretory organelles and regulates trafficking of a subset of secretory proteins in E. histolytica.
covalently associated with a glycosylphosphatidylinositol (GPI)linked light subunit (Lgl). This heterodimer is noncovalently
associated with a GPI-anchored intermediate subunit (Igl).
Other cell surface receptors include SREHP, a serine-rich
protein that is proposed to be lipid anchored (42), and
PATMK, a transmembrane kinase (2).
The complement of receptors found on the cell surface is
influenced both by anterograde and retrograde vesicle trafficking pathways. For example, newly synthesized proteins are
incorporated into the membrane of the endoplasmic reticulum
(ER), transported to the Golgi apparatus, and finally delivered
to the plasma membrane via anterograde transport vesicles.
On the other hand, cell surface receptors may be internalized
and delivered to intracellular compartments or back to the
plasma membrane via retrograde transport vesicles (44). While
E. histolytica trophozoites have been shown to possess an ER
and Golgi apparatus (8, 19, 41), insight into the molecular
mechanisms regulating the morphological and functional integrity of these organelles is limited. Such insight would contribute to our understanding of phagocytosis, which relies on
the proper functioning of these organelles for localization of
cell surface receptors.
In other systems, secretory vesicle trafficking events are regulated by Rab GTPases, a family of GTP-binding proteins
involved in the docking and fusion of transport vesicles with
target membranes. Substantial evidence suggests that Rab proteins carry out their function by cycling between a GDP-bound
cytosolic form and a GTP-bound membrane form (reviewed in
reference 39). In silico genome mining has shown that E.
histolytica possesses greater than 90 Rab GTPases (34). A
number of these exhibit limited homology to other known

Entamoeba histolytica, a protozoan parasite, is the causative
agent of amoebic dysentery and causes liver abscess. It is prevalent in developing countries that cannot prevent its fecal-oral
spread and is responsible for considerable global morbidity
and mortality (reviewed in reference 12). Infection is acquired
by ingestion of the cyst form of the parasite. Excystation occurs
in the small intestine, and released amoeboid trophozoites
move to, and colonize, the bowel lumen. Here, the pathogen
acquires nutrients via phagocytosis of colonic bacteria, host
cells, and host cell debris. The ability of the pathogen to carry
out phagocytosis has been correlated to its virulence potential.
For example, phagocytosis-deficient mutants of E. histolytica
exhibit reduced pathogenicity in vitro and in vivo (24, 33), and
a noninvasive Entamoeba species, E. dispar, exhibits low rates
of phagocytosis (26).
Given the importance of phagocytosis to virulence, the identification of proteins that directly or indirectly regulate this
process has been the focus of a considerable research effort
(reviewed in references 16 and 23). Proteomic analyses of
purified phagosomes have identified numerous proteins that
may regulate phagocytosis in E. histolytica (2, 17, 22). Functional studies have identified several cell surface proteins as
possible phagocytic receptors. One such receptor, the galactose/
N-acetylgalactosamine-inhibitable lectin (Gal/GalNAc lectin) (6,
31), consists of a transmembrane heavy subunit (Hgl) which is
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Rabs and thus are considered unique to E. histolytica (34). We
previously reported that one of these unique Rabs, EhRabA,
may be involved in the regulation of polarization, motility, and
actin cytoskeletal dynamics (47, 48). In the current study, we
demonstrate that overexpression of the putatively GTP-bound
form of EhRabA results in the alteration of ER morphology,
mislocalization of two subunits of the Gal/GalNAc lectin, and
reduced phagocytosis, suggesting that this Rab plays a direct or
indirect role in cellular functions that contribute to virulence.

MATERIALS AND METHODS
Strains, culture, and assay conditions. E. histolytica trophozoites (strain HM1:IMSS) were cultured axenically in TYI-S-33 medium (7) in 15-ml glass screw
cap tubes at 37°C. Several assays were performed in serum-free E. histolytica
medium, TYI-33. Chinese hamster ovary (CHO) cells were grown at 37°C in
Dulbecco’s modified Eagle’s medium supplemented with fetal bovine serum
(10%, vol/vol), 100 U/ml penicillin-streptomycin, and 1 mM HEPES.
Antibodies. Specific antibodies recognizing the subunits of the Gal/GalNAc
lectin were gifts of W. A. Petri, Jr. (University of Virginia, Charlottesville). The
generation of specific antibodies recognizing EhRabA, calreticulin (gift of N.
Guillén, Unité de Biologie Cellulaire du Parasitisme, Institut Pasteur, Paris,
France), EhCP2, and SREHP (gifts of S. L. Stanley, Jr., Washington University
School of Medicine, St. Louis, MO) has been described elsewhere (9, 38, 48, 50).
Monoclonal and polyclonal antibodies recognizing the hemagglutinin (HA)
epitope were obtained from Roche Pharmaceuticals (Nutley, NJ) and Zymed
(South San Francisco, CA), respectively. The 10C3 mouse monoclonal antibody
recognizing the KDEL ER retention signal was obtained from Abcam (Cambridge, MA).
Western blot analysis. Western blot analysis of E. histolytica cell lysates was
performed as described previously (47). Dilutions for anti-EhRabA, anti-Hgl,
anti-Igl, anti-KDEL, or anti-SREHP primary antibodies were 1:1500, 1:5,000,
1:2,500, 1:250, and 1:800, respectively. Commercial polyclonal anti-HA antibody
was utilized at 2 g/ml. In all cases, Western blots were normalized by loading
equal cell number equivalents to each of the lanes.
Mutagenesis of the EhRabA cDNA and transfection of E. histolytica trophozoites. Mutagenesis was carried out by a PCR-based method to generate a
constitutively GTP-bound version of EhRabA (EhRabAQ84L). In particular, the
codon for glutamine (Q; CAA), at amino acid position 84, was changed to the
codon (CTA) for leucine (L) by using the QuikChange kit (Stratagene, La Jolla,
CA) according to the manufacturer’s protocol. Nucleotides encoding an Nterminal HA tag, a 5⬘-BamHI site, and 3⬘-SalI site were also incorporated into
the cDNA by PCR as described previously (47). The resulting PCR product was
digested with BamHI and SalI and ligated into the E. histolytica expression vector
pGIR209 (30) (gift of W. A. Petri, Jr., University of Virginia, Charlottesville),
which had been digested with BglII and SalI. This vector allows for the inducible
expression of exogenous proteins by the addition of tetracycline to the medium
and is cotransfected with a second vector, pGIR308, that encodes the tetracycline
repressor (30).
Exponentially growing trophozoites of E. histolytica were transfected with the
engineered vector as described previously (43). The transfected amoebae were
maintained in 6 g/ml G418 (for pGIR209) and 15 g/ml hygromycin (for
pGIR308), which were added to the medium. Mutant EhRabA (the “induced
mutant”) expression was induced by the addition of 5 g/ml tetracycline to the
culture medium for 24 h.
Measurement of phagocytosis. Uptake of human red blood cells (hRBCs; U.S.
Biological Corp., Swampscott, MA) was measured according to the methods of
Voigt et al. (45). Pretreatment of erythrocytes with calcium and the measurement of uptake of calcium-treated hRBCs were carried out according to the
methods of Boettner et al. (3).
IF microscopy. For immunofluorescence (IF) microscopy, wild-type or mutant
E. histolytica trophozoites were fixed with 4% (vol/vol) paraformaldehyde in
phosphate-buffered saline (15 min, room temperature [RT]). Following permeabilization with 0.2% (vol/vol) Triton X-100 in PBS (5 min, RT), nonspecific
binding sites were blocked by incubation with 3% bovine serum albumin–10%
goat serum–PBS (30 min, RT). The amoebae were then incubated with the
following dilutions of primary antibodies for 2 h at room temperature: polyclonal
anti-Hgl (1:500), monoclonal anti-Hgl (1:66), anti-Igl (1:100), anti-Lgl (1:66),
anti-KDEL (1:140), anti-calreticulin (1:100), anti-SREHP (1:100), anti-EhCP2
(1:100), or monoclonal anti-HA (1:83). In some cases, wild-type trophozoites
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were treated with brefeldin A (BFA; 100 g/ml, 4 h, 37°C) prior to staining with
primary antibodies.
Following primary antibody incubation, and where appropriate, the amoebae
were incubated with one of the following secondary antibodies: Alexa Fluor 488
(green) or Alexa Fluor 594 (red) conjugated to goat anti-mouse or anti-rabbit
immunoglobulin G (diluted 1:1,000 in 1% bovine serum albumin–phosphatebuffered saline; Invitrogen, Carlsbad, CA; 1 h, RT). In some instances, to stain
nuclei, propidium iodide (20 g/ml) was added for 10 min during secondary
antibody incubation. Stained trophozoites were mounted in SlowFade (Invitrogen) and observed using a Carl Zeiss (Thornwood, NY) LSM 510 laser scanning
confocal microscope.
Measurement of adhesion to erythrocytes. Adhesion of E. histolytica amoebae
to erythrocytes was assayed using a previously described rosette formation assay
(31). Briefly, trophozoites (1 ⫻ 105) and erythrocytes (1 ⫻ 106) were mixed in 500
l of TYI-33, centrifuged (200 ⫻ g, 4°C, 5 min), and incubated for 30 min on ice.
Following incubation, 450 l of the supernatant was removed and 50 l trypan
blue was added. Ten microliters of the resulting mixture was used for counting
on a hemacytometer. Adherent amoebae were defined as those with three or
more bound erythrocytes (31). In some instances, trophozoites were pretreated
with 55 mM galactose or 55 mM mannose for 30 min prior to exposure to
erythrocytes and were maintained in the presence of these sugars during exposure to erythrocytes.
Measurement of adhesion to host monolayers. Measurement of adhesion of
trophozoites to monolayers of CHO cells was carried out as described previously
(29).
Statistical analyses. All values are given as means ⫾ standard deviations (SD).
Statistical analyses were performed using GraphPad Instat V.3 with an unpaired
t test, Welch corrected (two-tail P value). P values of less than 0.05 were considered statistically significant. P values less than 0.01 or 0.001 were considered
highly statistically significant.

RESULTS
Generation of an E. histolytica mutant expressing a GTPbound form of EhRabA. To gain insight into the function of
EhRabA we generated an E. histolytica cell line that conditionally overexpressed a constitutively GTP-bound version of this
protein. The cDNA encoding EhRabA was modified in two
ways. First, the cDNA was mutagenized to change the codon
for glutamine (Q) at amino acid position 84 to that for leucine
(L), to generate a mutant version termed EhRabAQ84L. This
mutation was chosen based on an identical mutation made in
numerous other small-molecular-weight GTPases (5, 28, 35),
including a Rab5-like GTPase of E. histolytica (35). In other
systems, this mutation has been shown to dramatically slow
GTPase activity resulting in Rabs that are constitutively GTP
bound (40). Second, to distinguish mutant EhRabA from endogenous EhRabA, the 5⬘ end of the EhRabA cDNA was
modified to include nucleotides encoding the HA epitope (4).
The N-terminal fusion was chosen to avoid interference with
C-terminal structural elements responsible for membrane association of proteins belonging to the Ras superfamily (36).
The modified cDNA was inserted into the E. histolytica expression vector, pGIR209, which confers G418 (neomycin)
resistance and allows for tetracycline-inducible expression of
exogenous genes when introduced into trophozoites (30). A
standard electroporation protocol (43) was utilized to introduce the expression vector into trophozoites which had been
previously transfected with an additional plasmid, pGIR308.
This companion plasmid encodes the tetracycline repressor
protein, which is necessary for tetracycline inducibility. Transfection was confirmed by purification of the expression plasmid
from stably transfected cell lines as described previously (43)
and sequencing of the cDNA insert (data not shown).
Maximum expression of modified EhRabA was achieved by
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FIG. 1. Expression of endogenous and mutant EhRabA in cell lysates from wild-type cells or transformed cells before (uninduced mutant) and
after (induced mutant) induction with tetracycline for 24 h. (A) Cell lysates from wild-type, uninduced, and induced mutant cell lines were resolved
by SDS-PAGE and protein was detected by Western blotting using antibodies specific for EhRabA or to the HA epitope. (B) IF microscopy of
wild-type (a to c) and mutant (e to g) cells using anti-EhRabA and anti-HA antibodies. Colocalized antigens are shown in yellow (c and g), and
corresponding differential interference contrast microscopic images are provided (d and h). In wild-type cells, EhRabA localizes to small
cytoplasmic puncta (a), which do not colocalize with nonspecific HA-staining (b and c). In mutant cells, EhRabA localizes to small and large
cytoplasmic puncta. A fraction of EhRabA-positive puncta colocalize with the HA epitope (f and g). Bars, 10 m.

the addition of 5 g/ml tetracycline to the culture medium for
24 h. Western blot analysis using anti-EhRabA antibody revealed two forms of the EhRabA protein in transformed cells
after induction with tetracycline: a lower-molecular-mass species (23 kDa) representing endogenous EhRabA, and a highermolecular-mass species (29 kDa) representing the HA-tagged
mutant version (Fig. 1A). The latter exhibited a molecular
mass that was slightly higher than expected; however, we cannot rule out the possibility that the mutation alters posttranslational modifications. Decreased prenylation and/or increased
methylation, two modifications normally seen on Rabs (13, 37),
would have resulted in a slower electrophoretic mobility.
An intermediate-molecular-mass protein was also detected
in the mutants by Western blotting with EhRabA-specific antibody. This protein species may represent a degradation product of the higher-molecular-mass species, as it was not recognized by HA-specific antibody (Fig. 1A). The HA-tagged
protein was not visible in lysates of wild-type cells or in lysates
of mutant cells prior to tetracycline induction (Fig. 1A), confirming the inducibility of the expression system. Longer inductions with tetracycline (48 to 72 h) did not result in higher
levels of the mutant protein as determined by Western blot
analysis (data not shown). Therefore, for all subsequent stud-

ies, expression of mutant EhRabA was induced by the addition
of tetracycline 24 h prior to experimentation.
In a previous study we demonstrated that EhRabA localized to small vesicles in the cytoplasm or in extending membranes of motile cells (48). IF staining using antibodies
specific for EhRabA or for the HA epitope demonstrated
that EhRabAQ84L also localized to both small and large
puncta throughout the cytoplasm (Fig. 1B). The mutant
protein was rarely observed to accumulate in membrane
extensions.
Expression of GTP-bound EhRabA reduces phagocytosis.
Previously, EhRabA was shown to localize to cellular extensions in the leading edge of motile trophozoites (48). Since
extension of pseudopodia is required for some forms of phagocytosis, and since phagocytosis represents an important virulence function of E. histolytica, we measured uptake of hRBCs
in mutants expressing EhRabAQ84L. Wild-type and mutant
trophozoites were exposed to hRBCs for 10 min, after which
uptake of heme was quantified spectrophotometrically. Expression of EhRabAQ84L resulted in a statistically significant
reduction in erythrophagocytosis (Fig. 2A).
To gain further insight into phagosomal trafficking in the
engineered cell line, we exposed wild-type and mutant tropho-
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FIG. 2. Cells expressing EhRabAQ84L exhibit reduced erythrophagocytosis. (A) Wild-type cells and cells expressing EhRabAQ84L were
exposed to erythrocytes for 10 min, after which the level of ingested heme was measured by spectrophotometry. The data are reported as the
percentage of uptake by wild-type cells, which was arbitrarily set to 100%. Uptake by the mutants was significantly lower than that of wild-type cells.
ⴱⴱ, P ⬍ 0.01. The data represent the means ⫾ SD of four trials. (B) Wild-type cells and cells expressing EhRabAQ84L were exposed to erythrocytes
for 40 min. At the indicated times, trophozoites were collected by centrifugation and the level of ingested heme was measured by spectrophotometry. The data are reported as means ⫾ SD of absorbance at 405 nm for four trials. While mutant cells took up less heme overall, both cell
lines exhibited similar kinetics of uptake.

zoites to hRBCs for time periods of up to 40 min. At regular
intervals, samples of trophozoites were taken and the level of
internalized heme was quantified. Although the cell line expressing EhRabAQ84L internalized less heme overall, both
wild-type and mutant cells exhibited an increase in heme accumulation up to 30 min, after which steady-state kinetics were
apparent (Fig. 2B). That both cell lines displayed similar kinetics suggests that intracellular trafficking or maturation of
phagosomes may not be altered in the mutant. Rather, the
reduction in hRBC uptake by the engineered cell line may be
the result of a defect in an early stage(s) of erythrophagocytosis, such as adhesion to the target.
Expression of GTP-bound EhRabA alters galactose-sensitive adhesion to hRBCs. To specifically examine early erythophagosomal events in the mutants, we measured their ability to adhere to erythrocytes by using a standard rosette assay

(31). Mutant cells were less efficient at binding hRBCs than
wild-type cells (Fig. 3A), suggesting that this early erythrophagosomal event was inhibited by expression of EhRabAQ84L.
Since E. histolytica trophozoites rely, in part, on the Gal/
GalNAc lectin for adhesion to hRBCs (31), we also determined whether galactose or mannose (negative control)
could inhibit the interaction between mutant cells and
hRBCs. In wild-type cells, galactose was capable of reducing
adhesion to hRBCs by approximately 47%, whereas in mutant cells, the same concentration of galactose inhibited
adhesion to hRBCs by 32% (Fig. 3B). Reduced sensitivity of
the mutant to galactose inhibition suggests decreased functionality for the Gal/GalNAc lectin in these cells. Mannose
was incapable of inhibiting parasite-hRBC interactions for
either cell line (Fig. 3B), indicating that the observed inhibition of adhesion by galactose was authentic.
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FIG. 3. Mutant cells exhibit reduced adhesion to hRBCs. The ability of wild-type and mutant cells to adhere to hRBCs was determined by a
standard rosette assay in the absence (control) and presence of galactose or mannose. (A) Mutant cells were less efficient at binding hRBCs
compared to wild-type cells. ⴱⴱ, P ⬍ 0.01. (B) While incubation in the presence of galactose significantly reduced adhesion of both cell lines to
hRBC targets, galactose was less efficient at inhibiting adhesion of mutant cells compared to wild-type cells. ⴱⴱⴱ P ⬍ 0.001; ⴱⴱ, P ⬍ 0.01. Mannose
did not significantly (i.e., nonsignificantly [NS]) reduce adhesion of either cell line to host cell targets, indicating that galactose-mediated inhibition
of adhesion was authentic. For both panels A and B, the data represent the means ⫾ SD of five trials and are reported as a percentage of adhesion
of control cells to hRBCs, which was arbitrarily set to 100%.

Expression of GTP-bound EhRabA alters the subcellular
localization but not levels of subunits of the Gal/GalNAc lectin. The finding that cells expressing EhRabAQ84L were less
sensitive to galactose inhibition of adhesion provided the impetus to examine the subcellular localization and the level of
Gal/GalNAc lectin subunits in these cells. IF microscopy demonstrated that, in mutant cells, Hgl was minimally localized to
the plasma membrane but was found to be enriched in large
tubular intracellular compartments (Fig. 4A, panel c). This
differed from the pattern observed in wild-type cells, where
Hgl was localized mainly to the cell periphery and to puncta
throughout the cytosol (Fig. 4A, panel a). Since Hgl possesses the ligand binding site, the altered localization of this

subunit in the mutants may lead to their reduced ability to
bind hRBCs.
We also examined the subcellular localizations of the other
subunits of the Gal/GalNAc lectin. In the mutant cells, Lgl
exhibited a similar localization to that of Hgl, concentrating in
an intracellular tubular network (Fig. 4A, panel k). Lgl is
covalently attached to Hgl through disulfide bridges (14);
therefore, it was not surprising to observe an altered localization of Lgl. Interestingly, the distribution of Igl in mutant cells
(Fig. 4A, panel g) did not differ from that in wild-type cells
(Fig. 4A, panel e). In both cell types, Igl was localized to a
significant number of cytoplasmic puncta. Together, these data
suggest that EhRabA may directly or indirectly regulate the
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FIG. 4. Subcellular localization of the Gal/GalNAc subunits in wild-type cells and cells expressing EhRabAQ84L. (A) IF microscopy of
wild-type (a, e, and i) and mutant cells (c, g, and k) using anti-Hgl, anti-Igl, or anti-Lgl antibodies. Corresponding differential interference contrast
microscopic images are shown (b, d, f, h, j, and l). In wild-type cells, Hgl, Igl, and Lgl are found in puncta throughout the cytoplasm. In wild-type
cells, Hgl is also enriched at the plasma membrane. In mutant cells, Hgl and Lgl are localized to intracellular perinuclear compartments, whereas
Igl is localized to cytoplasmic puncta. Bars, 10 m. (B) Western blot analysis of trophozoite lysates from wild-type (WT) and mutant (Q84L) cells
performed with anti-Hgl or anti-Igl antibody.

trafficking of a subset of vesicles that are also responsible for
the localization of Hgl and Lgl, but not of Igl. The data also
demonstrate that Igl may be transported by vesicle trafficking
routes that differ from that of the Hgl-Lgl heterodimer.
Western blot analysis demonstrated that the levels of at least
two Gal/GalNAc subunits, Hgl and Igl, were not altered in the
mutant compared to wild-type parental cells (Fig. 4B). Therefore, the differences observed between the mutant and wildtype cell lines were not likely the result of changes in protein
levels. Given that antibodies recognize multiple isoforms of Lgl
in trophozoites (25), the level of this subunit was not assessed
by Western blot analysis.
Hgl-positive compartments colocalize with markers of the
ER but not of the Golgi apparatus. The novel Hgl-containing
organelle observed in the mutants was reminiscent of recently
described tubular compartments of the ER of E. histolytica
(41). Therefore, we counterstained these organelles with an
antibody specific for E. histolytica calreticulin (9), an ER-resident protein. Since the ER often assumes a perinuclear organization, we simultaneously stained cells with propidium iodide, a nuclear stain. Minimal colocalization of Hgl (Fig. 5A

panels a and b) or Lgl (Fig. 5B, panels a and b) and calreticulin
was observed in wild-type cells, whereas significant colocalization of the these antigens was observed in mutants (Fig. 5A,
panels e and f and B, panels e and f). Significant colocalization
of Hgl and Lgl with calreticulin suggests that both subunits are
mislocalized to the ER or the same novel compartment derived
from the ER. We also observed that the novel organelle was
perinuclear in its localization (Fig. 5A, panel g), further supporting the ER origin of this organelle.
To confirm the ER origin of the novel compartment we also
used an antibody specific for the ER retention signal, KDEL.
This antibody recognizes an array of proteins on Western blots
of mammalian cell lysates; however, it prominently stains two
mammalian ER-resident proteins, GRP78 (78 kDa) and
GRP94 (94 kDa) (27). Likewise, Western blot analysis of trophozoite lysates from untransformed and mutant E. histolytica
revealed an array of proteins (data not shown) with two prominent bands of 78 and 94 kDa (Fig. 6A). This suggested that
this antibody might be used to authentically label the ER in E.
histolytica trophozoites. While the Western blot assay was performed only to assess the utility of this antibody, it revealed
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FIG. 5. The heavy (A) and light (B) subunits of the Gal/GalNac lectin colocalize with calreticulin (ER marker). IF microscopy results are shown
for wild-type (A, panels a to c, and B, panels a to c) and mutant cells (A, panels e to g, and B, panels e to g) using anti-Hgl (A) or anti-Lgl (B) and
anti-calreticulin antibodies. The tubular compartment is perinuclear as determined by propidium iodide staining (A, panel g). Colocalized antigens
are shown in light blue (A, panels c and g) or yellow (B, panels c and g), and corresponding merged differential interference contrast microscopic
images (A, panels d and h, and B, panels d and h) are provided. Bars, 10 m.

that the 94-kDa species was more abundant in the mutant than
in the wild-type cell line. This may indicate an expansion of the
ER as a result of EhRabAQ84L expression. IF microscopy
with the anti-KDEL antibody revealed minimal colocalization
of Hgl with the KDEL marker in wild-type cells (Fig. 6B,
panels a to c) but near-complete colocalization of Hgl with the
ER marker in the mutant (Fig. 6B, panels e to g). This provides
support for the ER origin of this organelle.
To determine if the novel compartments arose by fusion
events between the ER and Golgi complex, we counterstained
wild-type and mutant cells with an antibody specific for
␤-COP. This antibody was previously shown to label Golgi
complex-like elements in this organism (46). We observed minimal colocalization of Hgl and the Golgi antigen in the mutant
cell line, suggesting that little mixing of these organelles occurred as a result of EhRabAQ84L expression (Fig. 6C).
Expression of GTP-bound EhRabA alters the subcellular
localization of a secreted cysteine protease, EhCP2. We have
shown that expression of EhRabAQ84L results in aberrant
trafficking of at least one transmembrane protein, Hgl. To test

the effect of mutant EhRabA expression on another class of
secretory proteins, namely, soluble proteins, we looked at subcellular localization of a secreted cysteine protease, EhCP2, by
IF microscopy. Like Hgl and Lgl, EhCP2 was mislocalized to
large tubular compartments in the mutant cell line (Fig. 7).
This suggests that the molecular machinery governing the
trafficking of Hgl and Lgl may be shared by this cysteine
protease and that EhRabA may directly or indirectly regulate this pathway.
Expression of GTP-bound EhRabA does not alter the localization of SREHP, a serine-rich protein of E. histolytica. It has
been proposed that a putatively lipid-anchored cell surface
serine-rich E. histolytica protein, SREHP, also participates in
the uptake of hRBCs by phagocytosis (42). Therefore, we examined the cellular levels and localization of SREHP in mutant and wild-type cells. Western blot (Fig. 8A) and IF (Fig.
8B) analyses indicated that both the levels and localization of
SREHP remained unchanged in the mutants. In both wild-type
and mutant cells SREHP localized to the plasma membrane
and to an intracellular network (Fig. 8B). Furthermore, like
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FIG. 6. The heavy subunit of the Gal/GalNac lectin colocalizes with KDEL (ER marker), but not ␤-COP (Golgi marker), in cells expressing
EhRabAQ84L. (A) Western blot analysis of trophozoite lysates from wild-type (WT) and mutant (Q84L) cells using anti-KDEL antibody.
Consistent with its specificity in mammalian cells, the antibody prominently recognizes two proteins of 78 kDa and 94 kDa. (B) IF microscopy of
wild-type (a to c) and mutant (e to g) cells by using anti-Hgl or anti-KDEL antibodies. (C) IF microscopy of wild-type (a to c) and mutant (e to
g) cells using anti-Hgl or anti-␤-COP antibodies. In both panels B and C, colocalized antigens are shown in yellow (c and g) and corresponding
differential interference contrast microscopic images (d and h) are provided. Bars, 10 m.

Igl, SREHP did not colocalize with Hgl in the novel compartment (Fig. 8B).
It has been reported that E. histolytica trophozoites preferentially phagocytose apoptotic host cells (10) and that
SREHP may serve as a receptor for such targets (42). Since
the localization of SREHP was unchanged in the EhRab
AQ84L-expressing cells, we predicted that these mutants
would take up apoptotic targets as efficiently as untrans-

formed cells. Therefore, we tested the ability of the mutants
to internalize erythrocytes that were pretreated with calcium. Such treatment induces the exposure of phosphatidylserine on the outer membrane of the hRBCs, which is a
hallmark of apoptosis (3) As predicted, phagocytosis of calcium-treated cells was not inhibited by expression of
EhRabAQ84L (Fig. 9), suggesting that the mutant cells
could efficiently adhere to apoptotic cells. Fixation of mam-
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FIG. 7. Subcellular localization of the Hgl and EhCP2 subunits in wild-type cells and cells expressing EhRabAQ84L. IF microscopy of wild-type
(a to c) and mutant (e to g) cells by using anti-Hgl or anti-EhCP2 antibodies. Colocalized antigens are shown in yellow (c and g), and corresponding
differential interference contrast (DIC) (d and h) microscopic images are provided. In wild-type cells, Hgl and EhCP2 are localized to the plasma
membrane and cytoplasmic puncta. Mutant cells exhibit near-complete colocalization in intracellular compartments, some of which are perinuclear. Bars, 10 m.

malian cells with paraformaldehyde can also induce exposure of phosphatidylserine on outer membrane leaflets (49),
recapitulating the apoptotic phenotype. Therefore, we also
tested the ability of mutants and wild-type cells to adhere to

fixed epithelial monolayers. Adhesion of mutant cells to
paraformaldehyde-fixed monolayers of CHO cells was comparable to that of wild-type parental cells (data not shown), further supporting the idea that expression of EhRabAQ84L does

FIG. 8. Subcellular localization of SREHP is unchanged in cells expressing EhRabAQ84L. (A) Western blot analysis of trophozoite lysates
from wild-type (WT) and mutant (AQ84L) cells using anti-SREHP antibody. Consistent with a previous report (50), the antibody recognizes a series
of proteins ranging in size from 47 to 52 kDa. There were no apparent changes in the level of SREHP in the mutant cell line. (B) IF microscopy of
wild-type (a to c) and mutant (e to g) cells using anti-Hgl (a and e) or anti-SREHP (b and f) antibodies. Colocalized antigens are shown in yellow (c and
g), and corresponding differential interference contrast microscopic images (d and h) are provided. In wild-type cells, both Hgl and SREHP are enriched
at the plasma membrane and localize to intracellular puncta. In mutant cells, SREHP appears to retain its plasma membrane enrichment, whereas Hgl
localizes to intracellular and, in some cases, perinuclear compartments. Bars, 10 m.
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FIG. 9. Interactions with senescing host cells are unaltered in the
mutant cell line. Phagocytosis of calcium-treated erythrocytes was not
altered by expression of EhRabAQ84L. Data represent the means ⫾
SD of four trials and are reported as the percentage of uptake by
wild-type cells, which was arbitrarily set to 100%. (NS, nonsignificant.)

not inhibit trafficking of cell surface receptors specific for
apoptotic host cells.
Treatment with BFA phenocopies expression of EhRabAQ84L.
BFA is a fungal metabolite that can disrupt secretory pathway
vesicle trafficking (11). For example, in mammalian cells, this
reagent can block egress of vesicles from the ER (21) and can
induce vesicularization of Golgi apparata (11). In E. histolytica,
BFA can alter the morphology of a population of Golgi-specific vesicles and inhibit the trafficking of a subset of secretory
proteins (15). Interestingly, in E. histolytica, BFA also induces
the formation of tubular structures that colocalize with an ER
marker, protein disulfide isomerase (15). These structures are
similar to those observed in the EhRabAQ84L-expressing cell
line; therefore, we explored whether EhRabA might regulate
vesicle trafficking pathways that are also sensitive to BFA treatment. We examined the localization of several cell surface and
secreted proteins after BFA treatment of wild-type cells. Interestingly, exposure to BFA recapitulated the EhRabAQ84Linduced phenotype in that Hgl, Lgl, and EhCP2 were aberrantly localized to a large intracellular tubular network (Fig.
10A), whereas the distributions of Igl and SREHP were unchanged (Fig. 10B). This suggests that EhRabA participates in
vesicle trafficking pathways that are also sensitive to BFA.
DISCUSSION
We have demonstrated that overexpression of a GTP-bound
mutant of EhRabA results in decreased phagocytosis of nonsenescing red blood cells but not of senescing red blood cells.
Overexpression of the mutant protein also induced the appearance of large tubular and perinuclear organelles that could be
stained with ER-specific marker antibodies, suggesting that
this novel compartment was of ER origin. The appearance of
the tubular organelles in the mutant cells supports the recent
finding that E. histolytica trophozoites possess a traditional
continuous ER (41).
The nature of the phagocytic defect in the mutants was likely
related to their inability to adhere efficiently to the targets.
This may have been caused by mislocalization of two subunits
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of the Gal/GalNAc lectin, Hgl and Lgl, to the novel ER-like
compartment. In these mutants, at least one other secretory
protein, EhCP2, was also mislocalized to the ER-like organelles; however, the cellular localization of two other cell
surface proteins, Igl and SREHP, was unchanged. Interestingly, the EhRabAQ84L phenotype was similar to that induced
by treatment with BFA. Together, the data suggest that
EhRabA directly or indirectly influences the morphological
integrity of the ER and the trafficking of a subset of secretory
proteins in E. histolytica. This report is the first to demonstrate
that distinct secretory pathways may exist in E. histolytica.
Point mutations in the GTPase domain of Rabs, which result
in reduced GTPase activity, can lead to either gain-of-function
(18) or loss-of-function phenotypes (35). Constitutively GTPbound Rabs are generally considered to be hyperactivated and,
therefore, have acquired a gain-of-function phenotype. However, in cases where a terminal vesicle fusion event relies on
GTP hydrolysis, overexpression of a hydrolase-dead mutant
may, in fact, result in a loss-of-function phenotype. It is not
known if the engineered glutamine-to-leucine point mutation
described here results in gain of function or loss of function for
EhRabA.
The localization of EhRabA to membrane protrusions (48)
suggests a role in late secretion. If overexpression of the hydrolyase-dead version of EhRabA blocks this process (loss of
function), it may lead to accumulation of cargo in secretory
organelles or an imbalance between anterograde and retrograde trafficking in favor of retrograde movement of secretory
proteins toward the ER. Localization of EhRabA near the
plasma membrane (48) may also suggest a role in regulating
retrograde vesicle trafficking. Expression of the GTP-bound
form of this Rab might accelerate retrograde vesicle movement
(gain of function) toward the ER. In all of these cases, secretory proteins would accumulate in the ER, which may lead to
an expansion of the ER (32).
It is not surprising that alterations in Rab function can lead
to changes in organellar morphology. Rabs influence the morphology of organelles by regulating intraorganellar or interorganellar fusion events and/or by regulating the entry in or exit
of transport vesicles. Since EhRabA does not localize to the
ER (48) it is possible that it is acting in trans through effector
proteins to promote intraorganellar or interorganellar fusion
of ER-derived compartments. In support of this, overexpression of GTP-bound Rab5 in Caenorhabditis elegans results in
the appearance of large fused ER-derived compartments reminiscent of those observed in this study (1). Like EhRabA, C.
elegans Rab5 does not localize to the ER but is thought to
promote intraorganellar fusion of the ER through effector
proteins.
A striking result of this study was that BFA treatment could
recapitulate the novel organellar phenotype associated with
overexpression of EhRabAQ84L. BFA is known to block ERto-Golgi trafficking (21), which could alter the balance between
anterograde and retrograde vesicle traffic. The similar phenotype in the EhRabAQ84L-expressing cells may support a
model in which trafficking to and from the ER is perturbed.
However, there is not complete phenotypic recapitulation by
BFA treatment, since others have shown that BFA-treated E.
histolytica cells do not exhibit reduced phagocytosis of at least
one phagocytic target, green fluorescent protein-expressing E.
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FIG. 10. Subcellular localization of secretory proteins after treatment of wild-type cells with brefeldin A. Cells were treated with 100 g/ml BFA
for 3 h, after which they were fixed and stained with antibodies specific for a variety of secretory proteins. (A) BFA treatment phenocopies
expression of EhRabAQ84L with respect to the localization of Hgl (b and f), calreticulin (a and i), Lgl (j), and EhCP2 (e). In treated cells these
proteins exhibit near-complete colocalization in intracellular compartments, some of which are perinuclear. (B) Similar to EhRabAQ84L overexpression, BFA does not alter the localization of Igl or SREHP. Colocalized antigens are shown in yellow (A, panels c, g, and k, and B, panels c and g)
and corresponding differential interference contrast images (A, panels d, h, and l, and B, panels d and h) are provided. Bars, 10 m.

coli (15). Therefore, it is likely that the resultant phenotype of
the mutant occurred through a different process than that
operating in BFA-treated cells. Importantly, BFA induces alterations in the secretory pathway by impairing the association

and dissociation of coat proteins on cellular membranes (11),
whereas Rabs are not thought to participate in the assembly or
disassembly of such protein coats.
It is interesting that the localizations of Igl and SREHP were
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unaffected by EhRabAQ84L expression. While Igl is proposed
to interact with the membrane via a GPI-anchored protein, the
lipid modification connecting SREHP to the membrane is not
known. GPI-anchored proteins can exit the ER in distinct
vesicles from other secretory proteins (20). Our data suggest
that such GPI-specific secretory pathways similarly exist in E.
histolytica. Although Lgl has also been proposed to be GPI
anchored (14), its location must be significantly influenced by
its covalent attachment to Hgl. It was also intriguing that the
intermediate subunit of the Gal/GalNAc lectin was properly
localized even when the heavy and light chains exhibited aberrant localization. This suggests that temporal and spatial
regulation of Igl may differ from that of the Hgl-Lgl heterodimer, which may have implications in the control of lectin
function, and thus virulence. This mutant provides a model cell
line in which such questions might be explored. Since at least
two cell surface proteins, Igl and SREHP, did not exhibit
aberrant localization, we do not believe that all secretory trafficking was perturbed in the mutant or that the cells were
under general metabolic stress, which might lead to organelle
expansion and dysfunction.
Expression of both the GDP-bound (47) and GTP-bound
(this study) forms of EhRabA leads to mislocalization Hgl. It
remains to be determined if aberrant localization of the Hgl
and other secretory proteins in mutant cell lines is a direct
effect of the perturbation of EhRabA function or an indirect
effect of organellar reorganization. Given the importance of
the Gal/GalNAc lectin to pathogenicity, distinguishing between these two possibilities will provide significant insight into
virulence mechanisms of E. histolytica.
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